
1. rev inst med trop sao paulo. 2015 dec;57(6):519-22. doi:
10.1590/s0036-46652015000600011.

hepatocellular carcinoma non-cirrhotic patient sustained virological
response hepatitis c treatment.

mattos aa(1), marcon pdos s(1), araújo fs(1), coral gp(1), tovo cv(1).

author information: 
(1)universidade federal de ciências da saúde de porto alegre, rs, brazil.

chronic infection hepatitis c virus (hcv) one main risk factors 
the development liver cirrhosis hepatocellular carcinoma. however, the
emergence hepatocellular carcinoma (hcc) non-cirrhotic hcv patients,
especially sustained virological response (svr) unusual event.
recently, suggested hcv genotype 3 may particular
oncogenic mechanism, factors involved cases well the
profile patients still fully understood. thus, present the
case non-cirrhotic fifty-year-old male hcv infection, genotype 3a, 
developed hcc two years treatment pegylated-interferon ribavirin, 
with svr, brazil.

doi: 10.1590/s0036-46652015000600011 
pmcid: pmc4727140
pmid: 27049708  [indexed medline]

